Clinical Trial Update: Oxidative Stress and Cardiovascular Morbidity in Sleep Apnea-Hypopnea Syndrome (SAHS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on oxidative stress and cardiovascular morbidity in sleep apnea-hypopnea syndrome (SAHS). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Sleep Apnea

Snippet

Sponsor: Hospital Universitario La Paz | Conditions: Sleep Apnea, Cardiovascular Diseases | Phase 4 | Status: COMPLETED